144 related articles for article (PubMed ID: 35347123)
1. GRP78 blockade overcomes intrinsic resistance to UBA1 inhibitor TAK-243 in glioblastoma.
Zhang X; Wu R; Tian C; Wang W; Zhou L; Guo T; Yu J; Wu C; Shen Y; Liu X; Yu R
Cell Death Discov; 2022 Mar; 8(1):133. PubMed ID: 35347123
[TBL] [Abstract][Full Text] [Related]
2. GRP78 determines glioblastoma sensitivity to UBA1 inhibition-induced UPR signaling and cell death.
Liu G; Yu J; Wu R; Shi L; Zhang X; Zhang W; Zhong X; Wang Y; Li H; Shen Y; Wu C; Yu R; Niu M; Liu X
Cell Death Dis; 2021 Jul; 12(8):733. PubMed ID: 34301924
[TBL] [Abstract][Full Text] [Related]
3. UBA1 inhibition contributes radiosensitization of glioblastoma cells
Wu C; Shen Y; Shi L; Zhang J; Guo T; Zhou L; Wang W; Zhang X; Yu R; Liu X
Front Pharmacol; 2023; 14():1073929. PubMed ID: 36959858
[TBL] [Abstract][Full Text] [Related]
4. GRP78 inhibitor HA15 increases the effect of Bortezomib on eradicating multiple myeloma cells through triggering endoplasmic reticulum stress.
Chen Y; Tao Y; Hu K; Lu J
Heliyon; 2023 Sep; 9(9):e19806. PubMed ID: 37809599
[TBL] [Abstract][Full Text] [Related]
5. Withaferin A triggers G2/M arrest and intrinsic apoptosis in glioblastoma cells via ATF4-ATF3-CHOP axis.
Tang Q; Ren L; Liu J; Li W; Zheng X; Wang J; Du G
Cell Prolif; 2020 Jan; 53(1):e12706. PubMed ID: 31642559
[TBL] [Abstract][Full Text] [Related]
6. Preclinical evaluation of the selective small-molecule UBA1 inhibitor, TAK-243, in acute myeloid leukemia.
Barghout SH; Patel PS; Wang X; Xu GW; Kavanagh S; Halgas O; Zarabi SF; Gronda M; Hurren R; Jeyaraju DV; MacLean N; Brennan S; Hyer ML; Berger A; Traore T; Milhollen M; Smith AC; Minden MD; Pai EF; Hakem R; Schimmer AD
Leukemia; 2019 Jan; 33(1):37-51. PubMed ID: 29884901
[TBL] [Abstract][Full Text] [Related]
7. PERK Regulates Glioblastoma Sensitivity to ER Stress Although Promoting Radiation Resistance.
Dadey DYA; Kapoor V; Khudanyan A; Thotala D; Hallahan DE
Mol Cancer Res; 2018 Oct; 16(10):1447-1453. PubMed ID: 29991528
[TBL] [Abstract][Full Text] [Related]
8. ER stress and UPR activation in glioblastoma: identification of a noncanonical PERK mechanism regulating GBM stem cells through SOX2 modulation.
Peñaranda-Fajardo NM; Meijer C; Liang Y; Dijkstra BM; Aguirre-Gamboa R; den Dunnen WFA; Kruyt FAE
Cell Death Dis; 2019 Sep; 10(10):690. PubMed ID: 31534165
[TBL] [Abstract][Full Text] [Related]
9. Isochaihulactone-induced DDIT3 causes ER stress-PERK independent apoptosis in glioblastoma multiforme cells.
Tsai SF; Tao M; Ho LI; Chiou TW; Lin SZ; Su HL; Harn HJ
Oncotarget; 2017 Jan; 8(3):4051-4061. PubMed ID: 27852055
[TBL] [Abstract][Full Text] [Related]
10. Protein Palmitoylation Regulates Cell Survival by Modulating XBP1 Activity in Glioblastoma Multiforme.
Chen X; Li H; Fan X; Zhao C; Ye K; Zhao Z; Hu L; Ma H; Wang H; Fang Z
Mol Ther Oncolytics; 2020 Jun; 17():518-530. PubMed ID: 33024813
[TBL] [Abstract][Full Text] [Related]
11. FKBP9 promotes the malignant behavior of glioblastoma cells and confers resistance to endoplasmic reticulum stress inducers.
Xu H; Liu P; Yan Y; Fang K; Liang D; Hou X; Zhang X; Wu S; Ma J; Wang R; Li T; Piao H; Meng S
J Exp Clin Cancer Res; 2020 Feb; 39(1):44. PubMed ID: 32111229
[TBL] [Abstract][Full Text] [Related]
12. Targeting the ABC transporter ABCB5 sensitizes glioblastoma to temozolomide-induced apoptosis through a cell-cycle checkpoint regulation mechanism.
Lee CAA; Banerjee P; Wilson BJ; Wu S; Guo Q; Berg G; Karpova S; Mishra A; Lian JW; Tran J; Emmerich M; Murphy GF; Frank MH; Frank NY
J Biol Chem; 2020 May; 295(22):7774-7788. PubMed ID: 32317280
[TBL] [Abstract][Full Text] [Related]
13. Asiatic acid induces endoplasmic reticulum stress and apoptotic death in glioblastoma multiforme cells both in vitro and in vivo.
Kavitha CV; Jain AK; Agarwal C; Pierce A; Keating A; Huber KM; Serkova NJ; Wempe MF; Agarwal R; Deep G
Mol Carcinog; 2015 Nov; 54(11):1417-29. PubMed ID: 25252179
[TBL] [Abstract][Full Text] [Related]
14. Ursodeoxycholic Acid Inhibits Glioblastoma Progression via Endoplasmic Reticulum Stress Related Apoptosis and Synergizes with the Proteasome Inhibitor Bortezomib.
Yao Z; Zhang X; Zhao F; Wang S; Chen A; Huang B; Wang J; Li X
ACS Chem Neurosci; 2020 May; 11(9):1337-1346. PubMed ID: 32239921
[TBL] [Abstract][Full Text] [Related]
15. Targeting PDGFRα-activated glioblastoma through specific inhibition of SHP-2-mediated signaling.
Sang Y; Hou Y; Cheng R; Zheng L; Alvarez AA; Hu B; Cheng SY; Zhang W; Li Y; Feng H
Neuro Oncol; 2019 Nov; 21(11):1423-1435. PubMed ID: 31232447
[TBL] [Abstract][Full Text] [Related]
16. Resveratrol synergizes with cisplatin in antineoplastic effects against AGS gastric cancer cells by inducing endoplasmic reticulum stress‑mediated apoptosis and G2/M phase arrest.
Ren M; Zhou X; Gu M; Jiao W; Yu M; Wang Y; Liu S; Yang J; Ji F
Oncol Rep; 2020 Oct; 44(4):1605-1615. PubMed ID: 32945472
[TBL] [Abstract][Full Text] [Related]
17. Cordycepin Augments the Chemosensitivity of Human Glioma Cells to Temozolomide by Activating AMPK and Inhibiting the AKT Signaling Pathway.
Bi Y; Li H; Yi D; Sun Y; Bai Y; Zhong S; Song Y; Zhao G; Chen Y
Mol Pharm; 2018 Nov; 15(11):4912-4925. PubMed ID: 30336060
[TBL] [Abstract][Full Text] [Related]
18. Genomic screening reveals ubiquitin-like modifier activating enzyme 1 as a potent and druggable target in c-MYC-high triple negative breast cancer models.
Jacob S; Turner TH; Cai J; Floros KV; Yu AK; Coon CM; Khatri R; Alzubi MA; Jakubik CT; Bouck YM; Puchalapalli M; Shende M; Dozmorov MG; Boikos SA; Hu B; Harrell JC; Benes CH; Koblinski JE; Costa C; Faber AC
PNAS Nexus; 2022 Nov; 1(5):pgac232. PubMed ID: 36712364
[TBL] [Abstract][Full Text] [Related]
19. NBM-BMX, an HDAC8 Inhibitor, Overcomes Temozolomide Resistance in Glioblastoma Multiforme by Downregulating the β-Catenin/c-Myc/SOX2 Pathway and Upregulating p53-Mediated MGMT Inhibition.
Tsai CY; Ko HJ; Chiou SJ; Lai YL; Hou CC; Javaria T; Huang ZY; Cheng TS; Hsu TI; Chuang JY; Kwan AL; Chuang TH; Huang CF; Loh JK; Hong YR
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072831
[TBL] [Abstract][Full Text] [Related]
20. NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells.
Yu Z; Xie G; Zhou G; Cheng Y; Zhang G; Yao G; Chen Y; Li Y; Zhao G
Cancer Lett; 2015 Oct; 367(1):58-68. PubMed ID: 26188279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
